This makes ipamorelin a promising candidate for further clinical development as it provides targeted GH release without the additional stress response typically associated with other GH secretagogues
Invitrogen, PA5-97789, RRID: AB_2812404), anti-HA (rabbit, 1:1,000, Cell Signaling, 3724), anti-Th (rabbit, 1:500
They are also believed to increase leptin sensitivity, as determined by decreased leptin levels in non-diabetic women with obesity who lost weight on exenatide
(PubMed) McDaniel MA, Maier SF, Einstein GO
, Peptides, , ,
However, measurements of IENFD and basic QST have not conclusively demonstrated their preferential involvement in PDPN